FDA Commissioner Dr. Margaret Hamburg called for "a new era of partnership" with drugmakers and greater regulatory flexibility in bringing new drugs to patients. "We see this model emerging where we don't just wait for an application to come to us," Hamburg said Friday at the annual meeting of the Massachusetts Biotechnology Council. "We engage with you early and work with you throughout the development process."

Related Summaries